Monday, June 27, 2022
Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse
  SocialTwist Tell-a-Friend  

  • The Consortium jointly, through Aztiq II HoldCo, has  completed the acquisition of a 100% stake in Alvogen Emerging Markets Holdings Limited, thereby becoming the leading shareholders in Lotus Pharmaceuticals and Adalvo
  • Róbert Wessman, Chairman and CEO of Alvogen and Founder of Aztiq Pharma Partners, will continue as Chairman of the board of Lotus and Adalvo.
  • The Consortium's collective industry experience, geographic reach, and commitment to sustainable development, creates a unique alliance of investors and leaders, with the financial strength to support the companies' continued development.

LONDON, May 10, 2022 /PRNewswire/ -- Aztiq Pharma Partners ("Aztiq"), a private equity company led by Alvogen Founder and Chairman Róbert Wessman, and Innobic (Asia) Company Limited ("Innobic") have completed the acquisition of a 100% stake in Alvogen Emerging Market Holdings Limited ("AEMH") from its existing shareholders in a $500 million deal to form a Pharma powerhouse with resources, networks and reach across the globe.

From the ceremony

With this deal, which is one of the largest pharma transactions in the world this year, the consortium becomes the leading shareholder in the global oncology pharmaceutical company Lotus Pharmaceuticals ("Lotus", TWSE ticker: 1795), and the owner of 100% shares in Alvogen Malta Holding Ltd., the shareholder of a fast-growing global business to business (B2B) pharmaceutical company Adalvo.

AEMH was previously owned by Alvogen Lux Holdings Sarl ("Alvogen").   Key shareholders in Alvogen include CVC Capital Partners and Temasek Holdings of Singapore, as well as Aztiq. Alvogen will remain a leading shareholder in the generics pharmaceutical company Alvogen US, including specialty pharma company Almatica, as well as being the second largest shareholder in global biosimilar company Alvotech.

The expertise that the members of the consortium bring is impressive: Robert Wessman has successfully grown private equity firm Aztiq from a small local business to a regional contender. Innobic is owned by the largest conglomerate in Thailand, PTT Group, and has built extensive commercial and business networks in the fast-growing ASEAN countries.

Aztiq is led by Robert Wessman, who will continue to serve as Chairman of the Board of Lotus and Adalvo.

This unique market knowledge along with strong support from shareholders will provide Lotus and Adalvo with a competitive advantage in a thriving industry, enabling them to become global leaders in the pharma industry. Both companies have the shared goal of making high-quality medicines accessible to patients around the world and with the expertise and resources that will be readily available to them, this goal will be further accelerated. From oral oncology to research for innovation to over-the-counter products, together Lotus and Adalvo will pave the way for global access to first-class treatments and medication.

Róbert  Wessman, Chairman and CEO of Alvogen and Founder of Aztiq, commented: "I am very proud to have witnessed the maturation of both Lotus and Adalvo. I would like to take this opportunity to thank the existing shareholders for their great support in transformation of both Lotus and Adalvo and at the same time I would like to welcome our new partner, as we look forward to carrying out the essential work of expanding access to medicines with the strong expertise which all parties bring. With the comprehensive geographic networks and solid market intelligence in ASEAN brought by PTT and Innobic, I believe that Lotus and Adalvo will have a compelling competitive advantage, which enables both Lotus and Adalvo to become global leaders in their sectors."

Dr. Buranin Rattanasombat, Senior Executive Vice President, Innovation and New Ventures, PTT and Chairman of Innobic (Asia), commented: I am very pleased with the success of this transaction, remarking this step as the beginning of the next chapter for the collaboration.  Innobic  is committed to explore and develop transformative therapies that improve access for patients in the Region. This collaboration will strengthen and enhance Lotus' competitiveness and Adalvo pharma presence  in ASEAN and globally."

About Aztiq

Aztiq is a long-term healthcare investor led by Alvogen's and Alvotech's Founder and Chairman Róbert Wessman.   Aztiq, whose key investment focus is on pharmaceutical assets, is currently a leading and co-leading shareholder and operator of the following pharmaceutical assets:

Lotus – A leading global pharmaceutical company (

Adalvo  â€“ Global B2B pharmaceutical company (

Alvotech  â€“ A global biosimilar company (

Alvogen US / Almatica  â€“ US generics (Gx) and Specialty Pharmaceutical company.   (  /

Established in 2009, Aztiq was founded on the principle that everyone should have the right to medicine, regardless of their financial means.  

Róbert Wessman, has led over 50 strategic acquisitions and partnerships and established operations in over 60 countries. Wessman, alongside his seasoned team in Aztiq, continues to successfully launch and scale both industry-leading generic pharmaceutical and biosimilar companies all over the world.

Media Enquiries:

Lára Ómarsdóttir  
+354 659 9166                                                                                                                                                                          


Photo -
Logo -





More News by PR Newswire India

IAS Announces Campaign Sync Solution with Xandr's Invest DSP to Match Advertisers' Pre- and Post-bid Settings

Shahani Group Chairperson Mrs Maya Shahani Featured in The Knowledge Review's 2022 Listing of India's Most Admired Women in the Education Sector

Court Lifts Final Injunction in Favor of Altair in World Programming Case

Medvarsity partners with McGraw Hill to augment its courses and improve learning outcomes

PHD Media and 1862 OML win big at the Inkspell Media's MarTech Fest held on 24th June in New Delhi

Sigmoid strengthens financial services, industrial, and media offerings with accelerators and hiring deep domain experts

Thailand Draws on Creativity, Technology to Answer Consumer Demand for Eco-Friendly Lifestyle Goods

JOYSBIO offers SARS-COV-2 Antigen Rapid Test that detects Omicron subvariants BA.4 and BA.5

Global Secure SD-WAN Solutions Thrive as Organizations Turn to Cloud and 5G

Top 3 Countries for Future Growth Potential: The United States, Norway, and the United Kingdom

Abcam: Appointment of Vice President of Investor Relations

LIXIL announces winners and continuing support of the Asia Pacific Property Awards 2022-23

The 7th edition of the Embedded Safety & Security Summit culminated with a triumph

Myntra StyleCast rolls out Campus Ambassador Program, kick starting the journey for ~500 aspiring young creators from leading colleges

CSM Tech wins IMC Awards for transformation at JSW mines

12th DBN Science and Technology Award Ceremony to Further Broaden the Vision of Agricultural Innovation

Petal Search wins iF Award 2022, signaling its dedication to next-generation search engine

Hisense Praises Women Football Players through #RememberTheName Campaign, Commits to Enhancing Tournament Experience

CGTN: Why China's development philosophy can help promote global prosperity

Theme song "We Will Be Better" echoes 25th anniversary of HK's return to motherland

Amit Shah chairs Parliamentary Consultat...
Jharkhand Health Minister boycotts Centr...
SC to hear on Monday pleas by Shinde, re...
Jharkhand Bypolls: Cong's Shilpi Neha Ti...
Drugs worth about Rs 15 cr seized in Ass...
Apple offers students with discounts on ...
 Top Stories
PM Modi inspired India to dream big... 
BCCI advises players in England to ... 
Biden walks upto PM Modi at G7 Summ... 
Trailer of Gujarati film 'Vickida N... 
Pakistan irked over BRICS meeting s... 
G7 nations unite to address evolvin... 
Dharm Guru offers puja in Indore ci... 
Formula 1 pushing towards net zero ...